Literature DB >> 12890826

Cirrhosis with steatohepatitis following longterm stilboestrol treatment.

L Cooper, M Palmer, K Oien.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890826      PMCID: PMC1770016          DOI: 10.1136/jcp.56.8.639

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  Cirrhosis with steatohepatitis after adjuvant tamoxifen.

Authors:  K A Oien; D Moffat; G W Curry; J Dickson; T Habeshaw; P R Mills; R N MacSween
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

2.  Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.

Authors:  H Endo; T Murakami; I Nishimoto; I Sekine; M Yokoyama
Journal:  Acta Pathol Jpn       Date:  1987-05

Review 3.  The role of diethylstilbestrol in the treatment of prostate cancer.

Authors:  S B Malkowicz
Journal:  Urology       Date:  2001-08       Impact factor: 2.649

4.  Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes.

Authors:  A Berson; V De Beco; P Lettéron; M A Robin; C Moreau; J El Kahwaji; N Verthier; G Feldmann; B Fromenty; D Pessayre
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

5.  Association of hepatocellular carcinoma and a hyperplastic nodule after phosphate diethylstilbestrol therapy.

Authors:  T Takata; T Koga; O Miyanaga; N Sakakibara; Y Miyamoto; H Ishibashi
Journal:  Gastroenterol Jpn       Date:  1990-04

Review 6.  Nonalcoholic steatohepatitis.

Authors:  B A Neuschwander-Tetri; B R Bacon
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

7.  [Liver disorder owing to estrogen therapy in prostatic cancer, examined histopathologically in six autopsy cases].

Authors:  T Yamauchi; M Kokuho; S Yoshino; Y Tachibana; T Kawai; T Kitagawa
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1989-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.